- Home
- Our company
- Social impact
- Global health equity
- Improving access to care and services
Improving access to care and services
We collaborate with public and private sector organizations to expand access to care and services to improve global health.
Featured stories
Janssen, the Pharmaceutical Companies of Johnson & Johnson, Announces First-of-its-Kind Drug Donation Program for HIV Treatment-Experienced Children
Sub-Saharan African Ministries of Health Invited to Submit Expression of Interest to Participate in New EffortDonation Program to be Part of Broader Initiative to Raise Awareness and Action
Johnson & Johnson secures a top spot on the 2016 Access to Medicine Index
The index looks at companies that do the best job of providing access to medications in developing countries. Johnson & Johnson ranked #2—and here’s why.
More from Johnson & Johnson
Using your own cells to fight cancer
Cell therapy is bringing the world one step closer to eliminating cancer. Here’s how Johnson & Johnson has treated more than 10,000 patients and counting with this cutting-edge therapy.
These Johnson & Johnson leaders are breaking new ground in healthcare
Kimberly Lounds Foster, Soumya D. Chakravarty and Carmen Canovas Vidal are part of a new wave of innovators bringing their expertise in STEM into the heart of healthcare.
“I refuse to let lupus get me down”
Diagnosed with systemic lupus erythematosus (SLE) almost two decades ago, Laurie Bean has chosen a lifestyle that helps her battle debilitating side effects and the emotional fallout of this autoantibody disease.